NumFOCUS is pleased to announce Moderna as our newest Corporate Sponsor at the Bronze level.
“Moderna aspires to be the world’s first truly digital biotech company. In pursuing that vision, computational scientists and software developers rely on NumFOCUS-sponsored projects every single day,” said Iain McFadyen, Head of Computational Sciences at Moderna.
“We develop new tools and algorithms on a foundation of Pandas, NumPy, SciPy and Matplotlib, all within Jupyter Notebooks.
The contributions of the countless people giving their time to these and other projects makes our work possible. “
“We develop new tools and algorithms on a foundation of Pandas, NumPy, SciPy and Matplotlib, all within Jupyter Notebooks. The contributions of the countless people giving their time to these and other projects makes our work possible. Sponsoring NumFOCUS is a tangible way for us to recognize their hard work and to contribute to the continued success of truly essential tools.”
Moderna joins the ranks of NumFOCUS Corporate Sponsors who are stepping up to provide sustainable support for the open source projects that power their business success. NumFOCUS is grateful to Moderna and all of our sponsors for their generous support.
Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Moderna’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and cardiovascular diseases, independently and with strategic collaborators.
Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca, Plc. and Merck, Inc., as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense and the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). Moderna has been ranked in the top ten of Science’s list of top biopharma industry employers for the past four years. Join our team.
About NumFOCUS Corporate Sponsors
NumFOCUS Corporate Sponsors are for-profit companies who drive their business success using our open source projects. Corporate Sponsors invest in the development and sustainability of the open source scientific data stack through their financial support of NumFOCUS. Many sponsors also allocate employee paid time to development work on NumFOCUS open source projects.